Anastasia Levitin

Anastasia Levitin is a Professor of Practice in Translational Medicine at the Keck Graduate Institute (KGI), affiliated with the Riggs School. She joined KGI in 2013 and serves as Program Director for the MS in Applied Life Sciences, MCHA in Community Health Administration, and the Advanced Skills Training in Medical Assistance workshop. Her academic background includes a BSc and PhD in Biology/Biochemistry from Concordia University, Canada, with postdoctoral training at McGill University, Stanford University School of Medicine, and the National Research Council of Canada.

Dr. Levitin’s research focuses on host-pathogen interactions and microbial toxin mechanisms, emphasizing drug repurposing for infectious diseases. Key projects include anthrax toxin inhibition, bacterial pathogen drug screening, and Drosophila models for infection studies. She explores adaptive antibiotic resistance mechanisms and develops host-targeted therapies to combat antimicrobial resistance. Her work bridges basic research with translational applications, offering novel solutions for infectious disease treatment.

Publications highlight her contributions to anthrax therapy, Drosophila infection models, and broad-spectrum antibacterial agents. Her research demonstrates cross-disciplinary innovation, addressing urgent global health challenges in microbiology and clinical therapeutics.